Centro Medico Esperia

Aug 15, 2024 | jamanetwork.com | Mark Goldstein |Luca Mascitelli |Centro Medico Esperia |Richard Martin

Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality Richard M. Martin, BM, BS, PhD; Emma L. Turner, PhD; Grace J. Young, MSc; Chris Metcalfe, PhD; Eleanor I. Walsh, MSc; J. Athene Lane, PhD; Jonathan A. C. Sterne, PhD; Sian Noble, PhD; Peter Holding, MSc; Yoav Ben-Shlomo, MBBS, PhD; Naomi J. Williams, PhD; Nora Pashayan, MD, PhD; Mai Ngoc Bui, PhD; Peter C. Albertsen, MD; Tyler M. Seibert, MD, PhD; Anthony L. Zietman, MD; Jon Oxley, MD; Jan Adolfsson, MD; Malcolm D.

Mar 14, 2024 | thelancet.com | Mark Goldstein |Luca Mascitelli |Centro Medico Esperia

The interesting paper of Paul M Ridker and colleagues,1Ridker PM Bhatt DL Pradhan AD et al. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials.

Nov 7, 2023 | jamanetwork.com | Mark Goldstein |Luca Mascitelli |Steven Nissen |Centro Medico Esperia

Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients Steven E. Nissen, MD; Venu Menon, MD; Stephen J. Nicholls, MBBS, PhD; Danielle Brennan, MS; Luke Laffin, MD; Paul Ridker, MD; Kausik K. Ray, MD, MPhil; Denise Mason, BSN; John J. P. Kastelein, MD; Leslie Cho, MD; Peter Libby, MD; Na Li, PhD; JoAnne Foody, MD; Michael J. Louie, MD, MPH, MSc; A. Michael Lincoff, MD Bempedoic Acid for Primary Prevention of Cardiovascular Events—Reply Steven E.